Oxidative stress can cause injury in retinal endothelial cells. Carboxymethyl cellulose modified with collagen peptide (CMCC) is of a distinct antioxidant capacity and potentially a good drug carrier. In this study, the protective effects of CMCC against Therefore, it could be concluded that CMCC provides a promising platform to enhance the drug-based therapy for I/R-related retinal injury.
carboxymethyl cellulose, as functional medical materials, has been found to be able to reduce the high level of ROS. 14, 15 However, this antioxidative capability of carboxymethyl cellulose against ROS was rather limited. 16 An improving approach was modifying the cellulose with a stronger antioxidative group. Collagen peptide was known for its abundant physiological functions, such as chemotaxis, platelet aggregation, suppressing osteoclast differentiation and, in particular, protecting against oxidative free radical. [17] [18] [19] Thus, the functionalization of carboxymethyl cellulose with collagen was expected to effectively improve its antioxidative capacity.
IL-10, a potent anti-inflammatory cytokine, is known for its potent capacity that hampered inflammation and modulated pathogenesis of inflammatory syndromes. 20 The IL-10 has been found to play a critical protective role in multiple inflammatory diseases, such as inflammatory bowel disease, experimental allergic encephalomyelitis and atherosclerosis. [21] [22] [23] In this study, we prepared carboxymethyl cellulose grafted collagen peptides and investigated its antioxidative property in vitro against H 2 O 2 -simulated oxidative stress environment. Then, IL-10-loaded antioxidative gels were delivered into the eyes of rats after retinal I/R injury for practical attempts. In addition, we preliminarily studied the underlying mechanism of enhanced restoration of retina from apoptosis with IL-10-loaded antioxidative gels by investigating the level of antioxidant enzyme and the mRNA expression of inflammatory cytokines.
| MATERIALS AND METHODS

| Materials
The commercial collagen peptide (M w = 800) was purchased from
Huashun Biological Technology Co. Ltd., China. The other chemicals at least analytical purity, including N-Hydroxy sulfosuccinimide (NHS), 2-(N-morpholino) ethanesulfonic acid (MES) and 1-ethyl-(dimethylaminopropyl) carbodiimide (EDC), were purchased from Sinopharm Chemical Reagent Co., Ltd., China. Interleukin-10 (IL- 10) and sodium carboxymethyl cellulose (M w = 7.8 × 10
3 ) were purchased from Sigma-Aldrich. The culture medium was renewed every 48 hours when the cells were grown up to 80%-90% confluence.
| Preparation of carboxymethyl cellulose grafted collagen peptide
The synthetic approach was based on the previous method. 24 Typically, first, carboxymethyl cellulose was first dissolved with magnetic stirring, followed by NHS-EDC coupling reaction (EDC:CMC, 1:2).
Then, after reacting for 1 hour, collagen peptide with the mass ratio of 5:3 to CMC was added into the mixture and the grafting reaction was undertaken in MES buffer (pH 6) for 20 hours at 55°C with a constant vigorous stirring. The final products, carboxymethyl cellulose grafted collagen peptide (CMCC), were lyophilized and stored before dialysis for 3 days.
| Isolation and culture, viability and identification of retina endothelial cells
Three-week-old male Sprague-Dawley (SD) rats were applied to the isolation of primary retina endothelial cells (rRECs), according to previous protocol. 25 Typically, rats eyes were first enucleated and hemisected. The retinas were separated with a dissecting microscope, immersed in HBSS in the presence of penicillin/streptomycin (Sigma) and rinsed. A total of twenty-four retinas were undertaken digestion with 0.5% collagenase type I (Worthington, NJ) in serum-free DMEM for 45 minutes at 37°C. Then, endothelial cell-specified medium containing 1% ECM (5% foetal bovine serum, 100 mg/mL streptomycin and 100 U/mL penicillin ScienCell Research Laboratories, CA) was supplemented. The obtained cells undertook filtering through 70-and 40-μm nylon mesh (Becton, USA), successively, and were redispersed in ECM followed by incubating with goat antimouse magnetic beads pre-coated via mouse anti-rat PECAM-1. After thoroughly washing with HBSS for 6 times and resuspending in ECM, the beads contained solution was then seeded on 6-well plates pre-treated with human fibronectin (Thermo Fisher Scientific, USA). TUNEL staining (green) images were attained through the Flouview-FV300 Laser Scanning Confocal system (Olympus, Japan).
| Western blotting assay
The proteins of lysed rRECs and retina were analysed using BCA 
| IL-10 loading and releasing assay in vitro
The IL-10 loading CMCC (IL-10@CMCC) was obtained by soaking CMCC in saturated IL-10 solution overnight at 4°C. The releasing assay of IL-10@CMCC was performed using ELISA to detect the released IL-10. Briefly, aliquots of the IL-10@CMCC were separately dispersed and standing in 5 mL 1 × PBS (pH7.4). Subsequently, the supernatants were collected and analysed at different days. Each sample was repeated 3 times.
| Retinal ischaemia/reperfusion injury
Sprague-Dawley rats with similar weights were anesthetized using sodium pentobarbital and then received surgery, performed as described previously. 27 Briefly, the anterior chambers of rat eyes were cannulated utilizing a 27-gauge infusion needle connected with a normal saline reservoir. The intraocular pressure was then tuned up to 110 mm Hg for 1 hours. The retinal ischaemia/reperfusion was verified through examining the fundus whitening and the retinal blood flow restoration.
| Injection of IL-10@CMCC into vitreous
The injection procedures followed a previous protocol with modification. 28 Briefly, after anaesthesia with ketamine (50 mg/kg) and phenergan (25 mg/kg), both pupils of rat eyes were dilated using 1% atropine and 1% compound tropicamide eye drops (Zhongshan Ophthalmic Center, China). 1% Tetracaine eye drops (Zhejiang Jiuxu Pharmaceutical Co., Ltd., China) was used for topical anaesthesia fol- 
| Measurement of retinal thickness
The retinal thickness of rats was measured as previously described. 29 In brief, the rats were first anaesthetized at day 21, followed by the enucleation of their eyes. The eyecups then successively underwent the 2-hours fixation in 4% paraformaldehyde, the 12-hours immersion in 30% sucrose solution, and the final embedment in OCT media (Sakura Finetek, USA), after removing cornea, lens and vitreous. 0.5 mm of retinal sections were cut off along the vertical meridian of eye and across the optic nerve head. The cut-off sections were stained with haematoxylin and eosin (H&E) and imaged via the light microscope. The retinal thickness measurements were taken at every 250 μm in a range of 800-1200 μm centralized at the optic nerve head.
| Immunofluorescence staining of Csp3
Typically, the cut-off retinal sections received fixing with 4% paraformaldehyde for 10 minutes, permeabilizing with 0.1% Triton X-100 for 15 minutes and blocking with 5% normal goat serum for 60 minutes. rRECs were then incubated with Csp3 antibody (1/200 diluted) overnight and secondary antibody modified with Alexa Fluor 568 for 1 hour (1/500 diluted, Molecular Probes, USA). DAPI staining was used as reference. Images were also attained via the Flouview-FV300 Laser Scanning Confocal system.
| Inflammation level assessment via quantitative polymerase chain reaction (PCR)
The extraction of total RNA from the retina was performed using
TRIzol reagent (Invitrogen-Life, USA). Then, 1 μg of total RNA was annealed with 300 ng of oligo (dT) (Promega, USA) for 5 minutes at 65°C, followed by reversely transcribing to cDNA utilizing 80U Moloney murine leukaemia virus reverse transcriptase (Gibco-life, USA) at 37°C for 1 hour. The obtained cDNA was applied to realtime qPCR using iTaq Universal SYBR Green Supermix (Bio-Rad) using a CFX96 Touch Real-Time PCR Detection System (Bio-Rad).
The following primers were used for amplification reaction: TNF-α: 
| Measurement of reactive oxygen species in retina
The chemilumigenic probes, luminol (5-amino-2,3-dihydro-1,4-phthalazinedione, Sigma) and lucigenin (bis-N-methylacridiniumnitrate, Sigma), were used to assess the ROS level in rat retina. 30 Briefly, 
| Measurements of the activities of antioxidant enzymes in retina
Colorimetric methods were aplicated to evaluate superoxide dismutase (SOD) and catalase (CAT) activities using kits (Cayman Chemical, USA) in the retina at day 3, 7 and 14. Assays were conducted according to the manufacturer's protocols.
| Measurements of glutathione levels in retina
Glutathione (GSH) ELISA kits (Cayman Chemical, USA) were used to determine the concentration of GSH. The absorbance of the dithionitrobenzoic acid (DTNB) method at 412 nm at days 3, 7 and 14 was recorded and then calculated to the expression of GSH level as μmol/mg protein.
| Statistical analysis
Digital data were expressed as mean ± SD. Statistical significance was denoted as P value < .05. The analysis within groups employed one-way ANOVAs followed by Tukey's post hoc test for multiple pairwise tests.
| RESULTS
| rRECs viability and identification
As can be seen in Figure 1A , the morphology of the isolated rRECs was fusiform. The PI evaluation showed that viable cells (PI-) reached 98.8%, indicating desirable isolation efficiency ( Figure 1B) .
Furthermore, the obtained cells were immunofluorescence stained with the specific biomarker of rRECs (factor VIII) and DAPI for cell nucleus. As shown in Figure 1C , the almost complete overlapping of the 2 markers indicated the high purity of rRECs.
| CMCC protect rRECs against H 2 O 2 -induced oxidative stress
The introduction of H 2 O 2 into rRECs culture medium was used to establish in vitro oxidative stress model and assess whether CMCC was able to strengthen the viability of rRECs under the condition. As shown in Figure 1D , The CMCC was known for its antioxidative capability. As predicted, the 500 μmol/L H 2 O 2 -induced decrease in rRECs viability can be considerably offset by the addition of this antioxidative gels ( Figure 1E ).
Furthermore, as shown in Figure 1F clearly indicated that apoptosis in the control group was significantly lower than H 2 O 2 -treated group and this change could be considerably ameliorated by supplementing antioxidative gels.
| Assessment of apoptotic proteins
The investigation of apoptotic proteins expression in rRECs further validated the underlying mechanism. As shown in Figure 3B , H 2 O 2 -induced oxidative stress significantly up-regulated pro-apoptotic protein, Csp3 and the ratio of Bax to Bcl-2. This modulation in rRECs was then significantly suppressed when the antioxidative gels, CCPCC, were introduced.
| In vitro assay of IL-10 releasing
The released IL-10 in supernatant was measured at days 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10, respectively (Figure 4 ). It can be seen that MU ET AL.
| 5011 about 25% amount of drugs were released at the first day. With time, the releasing speed was correspondingly decreased. At day 10, only 2% increase was detected, compared with the releasing amount at day 9, indicating the relative retention of loaded IL-10 in antioxidative gels.
| Effects of IL-10@CMCC on retinal histology after I/R injury
As shown in Figure 5A , retinal I/R injury obviously caused the decrease in retinal thickness, compared with normal group at day 21. Marked increase in retinal thickness was found in the I/ R + Gel group and this restoration was enhanced in the I/R + Gel/IL-10 group, compared with the I/R group. The data of bar plotting clearly supported the observation through H&E staining.
In addition, the thicknesses of inner plexiform layer (IPL), inner nuclear layer (INL) and outer nuclear layer (ONL) were generally reduced by the treatment of I/R ( Table 1 
| Effects of IL-10@CMCC on the expression of inflammatory cytokine
At day 3, as shown in Figure 6A -E, the mRNA expression levels of TNF-α, IL-1β, iNOS, ICAM-1 and MCP-1 were much higher in I/Rinjured group than the normal rats. In I/R + Gel, the expression of TNF-α, IL-1β, iNOS, ICAM-1 and MCP-1 significantly reduced, compared with that in I/R group (P < .05). Moreover, the mRNA levels of 
| Effects of IL-10@CMCC on the level of ROS and the activity of anti-oxidases
The changes in oxidative states in retinas were finally assessed by evaluating the level of ROS and the activity of antioxidant enzymes.
Lucigenin-and luminol-enhanced chemiluminescence (CL) methods revealed the in vivo ROS level at days 3, 7 and 14 respectively. As shown in Figure 7 , I/R injury could significantly trigger the CL in retina. The administration of antioxidative gels and IL-10 remarkably decreased the luminol-and lucigenin-enhanced CL signal over 2 weeks, compared with I/R group. Conversely, the activity of SOD and CAT as well as the level of GSH in retina was found significantly reduced in I/R group, compared with those in normal group, as shown in Figure 7C ,D. Such significant decrease in the activity of SOD and CAT enzymes and GSH level induced by I/R injury was considerably inhibited by the supplementation with antioxidative gels, CMCC, particularly loaded with IL-10 at days 3, 7 and 14.
| DISCUSSION
Oxidative stress and inflammation were reported to play key roles in retinal damage caused by I/R injury. 31, 32 Hence, drugs or treatments capable of attenuating ROS level or/and inflammation in retina are considered as efficacious and main therapies for retinal I/R injury.
31
H 2 O 2 was regarded as one of the most important species in ROS, due to its stability and key status in ROS-related metabolism. 33, 34 Thus, in vitro H 2 O 2 tests were gradually accepted as featured tools for the study of ROS or oxidative stress. 35, 36 Here, H 2 O 2 was employed to simulate in vitro oxidative stress microenvironment and F I G U R E 2 Representative TUNEL images of rRECs. The rRECs were pre-treated with or without H 2 O 2 and antioxidative gels. The blue was nucleus staining with DAPI and the green was TUNEL staining, representing apoptotic rRECs. Three groups. Bar scale = 100 μm rRECs were selected as model cells due to its physiological function of retinal vascularization, which is essential for structural and functional recovery of the retina. The therapeutic efficiency of this antioxidative gel cargo could be further enhanced by loading drugs. IL-10 was selected for its anti-inflammation drug potentials. 43 Previous studies have already utilized IL-10 to mitigate inflammatory response to I/R injury. 44, 45 For instance, the up-regulation of IL-10 through pre-conditioning with CpG-oligonucleotides could mitigate the myocardial I/R injury. 46 In this study, we demonstrated that IL-10 load enhanced the protec- was involved in the degeneration of inner retinal compositions owe to I/R injury. 49 The iNOS-triggered delayed neuronal cell death after ischaemia mediated the production of nitric oxide (NO), 50 which would finally develop into inflammatory oxidants. 51 ICAM-1 directly activated inflammatory responses to the blood vessel wall through stimulating endothelial cell and generating atherosclerotic plaque. 52 MCP-1 contributed to the combination between monocytes/macrophages and target tissues. 53 In this study, we clearly demonstrated that the drug-carrying platform, antioxidant gels loading with IL-10, could inhibit the expression of TNF-α, IL-1β, iNOS, ICAM-1 and MCP-1. Our results complied with those of previous studies, 54, 55 demonstrating that the gels and IL-10 synergistically displayed antiinflammatory activities through the expression inhibition of various inflammatory mediators.
Afterwards, another important factor to induce apoptosis after I/R, in vivo oxidative stress, was investigated. Previous studies have confirmed that I/R injury produced a myriads of ROS, including H 2 O 2 , OH -, hypochlorite, peroxynitrite and superoxide radicals, resulting in cellular damage and apoptosis. 3, 31 Our data of in vivo ROS analysis were consistent with that of the previous report, 27 indicating that I/R injury induced apoptosis in retina was accompanied by significant augment of ROS level. In addition, the decreases in oxidant scavenges, typically SOD, CAT and GSH, were found after I/R injury, 27 which further weakened the capacity of the degradation of intracellular ROS. In our study, the IL-10@CMCC hybrids were capable of ameliorating the augment of ROS level. After injecting these IL-10-loaded hydrogels, the expressive abnormity of ROS and oxidant scavenges was significantly offset, facilitating to recover retinal cells from apoptosis and ultimately retinal thickness as well as morphology. Albeit plausible results achieved in retinal treatment post-I/R injury, there is still a long way to improve therapeutic effects of drug-delivery system on the retina I/R injury. We hence need more endeavour to explore and optimize the in vivo performance of this slowreleasing system in the future. 
